These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 4707416

  • 21. [Clinical effect of a new saluretic drug: ethacrynic acid].
    D'Amico G, Romagnoni M, Scatolini G, Piane C, Castelluccio A, Cammi L, Rovelli E.
    Minerva Nefrol; 1968; 15(4):245-52. PubMed ID: 5745813
    [No Abstract] [Full Text] [Related]

  • 22. Early changes in the cochlear duct from ethacrynic acid: an electronmicroscopie evaluation.
    Quick CA, Duvall AJ.
    Laryngoscope; 1970 Jun; 80(6):954-65. PubMed ID: 5426728
    [No Abstract] [Full Text] [Related]

  • 23. [Administration of massive dosages of sodium and frosemide during the last stage of chronic renal failure, with special reference to hearing disorder].
    Kondo R, Sakaue M, Sato T, Kudo K, Ariga Y.
    Nihon Jinzo Gakkai Shi; 1975 Oct; 17(10):855-65. PubMed ID: 1241981
    [No Abstract] [Full Text] [Related]

  • 24. Diuretics in renal disease.
    Muth RG.
    Med Times; 1969 Oct; 97(10):239-50. PubMed ID: 5346573
    [No Abstract] [Full Text] [Related]

  • 25. Ototoxicity of loop diuretics.
    Rybak LP.
    Otolaryngol Clin North Am; 1993 Oct; 26(5):829-44. PubMed ID: 8233492
    [Abstract] [Full Text] [Related]

  • 26. Pharmacology of hearing and ototoxicity.
    Brown RD, Feldman AM.
    Annu Rev Pharmacol Toxicol; 1978 Oct; 18():233-52. PubMed ID: 348060
    [No Abstract] [Full Text] [Related]

  • 27. [Adverse effects of interest].
    Tidsskr Nor Laegeforen; 1971 Nov 30; 91(33):2427. PubMed ID: 5132025
    [No Abstract] [Full Text] [Related]

  • 28. Metoprolol-induced hyperkalemia in a diabetic with advanced renal failure.
    Ashouri OS.
    Arch Intern Med; 1985 Mar 30; 145(3):578. PubMed ID: 3977532
    [No Abstract] [Full Text] [Related]

  • 29. [The effect of the angiotensin-converting enzyme inhibitor enalapril on the rates of progression of chronic kidney failure in patients with different degrees of functional kidney disorders].
    Esaian AM, Kaiukov IG, Titova VA.
    Ter Arkh; 1995 Mar 30; 67(6):57-9. PubMed ID: 7667785
    [Abstract] [Full Text] [Related]

  • 30. Ethacrynic acid and related diuretics: relationship of structure to beneficial and detrimental actions.
    Koechel DA.
    Annu Rev Pharmacol Toxicol; 1981 Mar 30; 21():265-93. PubMed ID: 7016007
    [No Abstract] [Full Text] [Related]

  • 31. [Some complications following antibacterial therapy in patients with chronic renal insufficiency].
    Todorenko AD, Mel'man NIa.
    Vrach Delo; 1968 Feb 30; 2():128-30. PubMed ID: 5302194
    [No Abstract] [Full Text] [Related]

  • 32. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
    Sanaka T, Akizawa T, Koide K, Koshikawa S.
    Ther Apher Dial; 2004 Jun 30; 8(3):232-40. PubMed ID: 15154877
    [Abstract] [Full Text] [Related]

  • 33. [Advantages of insulin Lispro (short-acting) in terminal kidney failure].
    Jehle PM, Aisenpreis U, Bundschu D, Keller F.
    Fortschr Med; 1999 Apr 20; 117(11):41-2. PubMed ID: 10339922
    [Abstract] [Full Text] [Related]

  • 34. Hazards of ethacrynic acid.
    Chaffee WG.
    JAMA; 1970 Apr 06; 212(1):159. PubMed ID: 5467218
    [No Abstract] [Full Text] [Related]

  • 35. Hazards of ethacrynic acid.
    Merrill JP.
    JAMA; 1970 Apr 06; 212(1):159. PubMed ID: 5467219
    [No Abstract] [Full Text] [Related]

  • 36. [Transient deafness in patients with renal insufficiency treated with erythromycin].
    Kanfer A, Daniel F, Vigeral P, Méry JP, Haguet JF.
    Nouv Presse Med; 1979 Jun 16; 8(27):2283-4. PubMed ID: 493003
    [No Abstract] [Full Text] [Related]

  • 37. Angiotensin converting enzyme inhibitor and chronic renal failure.
    Sitprija V, Lumlertgul D.
    J Med Assoc Thai; 1993 Jul 16; 76(7):359-67. PubMed ID: 8089635
    [Abstract] [Full Text] [Related]

  • 38. Mode of action of ethacrynic acid in congestive heart failure.
    Porter GA, Bennett WH, Griswold HE.
    Arch Intern Med; 1968 Mar 16; 121(3):235-42. PubMed ID: 5642743
    [No Abstract] [Full Text] [Related]

  • 39. Acquired pincer nail deformity associated with end stage renal disease secondary to diabetes.
    Kirkland CR, Sheth P.
    Dermatol Online J; 2009 Apr 15; 15(4):17. PubMed ID: 19450410
    [Abstract] [Full Text] [Related]

  • 40. Transient and permanent deafness following treatment with ethacrynic acid in renal failure.
    Pillay VK, Schwartz FD, Aimi K, Kark RM.
    Lancet; 1969 Jan 11; 1(7585):77-9. PubMed ID: 4178003
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.